- Home
- IKNA vs ICLK Comparison
IKNA vs ICLK Comparison
Compare IKNA & ICLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- ICLK
- Stock Information
- Founded
- IKNA 2016
- ICLK 2009
- Country
- IKNA United States
- ICLK Hong Kong
- Employees
- IKNA N/A
- ICLK N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- ICLK Computer Software: Prepackaged Software
- Sector
- IKNA Health Care
- ICLK Technology
- Exchange
- IKNA Nasdaq
- ICLK Nasdaq
- Market Cap
- IKNA 81.6M
- ICLK 73.0M
- IPO Year
- IKNA 2021
- ICLK 2017
- Fundamental
- Price
- IKNA $1.45
- ICLK $9.09
- Analyst Decision
- IKNA Buy
- ICLK
- Analyst Count
- IKNA 2
- ICLK 0
- Target Price
- IKNA $3.00
- ICLK N/A
- AVG Volume (30 Days)
- IKNA 134.5K
- ICLK 68.6K
- Earning Date
- IKNA 03-11-2025
- ICLK 11-27-2024
- Dividend Yield
- IKNA N/A
- ICLK N/A
- EPS Growth
- IKNA N/A
- ICLK N/A
- EPS
- IKNA N/A
- ICLK N/A
- Revenue
- IKNA $659,000.00
- ICLK $130,443,999.00
- Revenue This Year
- IKNA N/A
- ICLK $26.49
- Revenue Next Year
- IKNA N/A
- ICLK $12.11
- P/E Ratio
- IKNA N/A
- ICLK N/A
- Revenue Growth
- IKNA N/A
- ICLK N/A
- 52 Week Low
- IKNA $1.22
- ICLK $1.03
- 52 Week High
- IKNA $1.94
- ICLK $11.38
- Technical
- Relative Strength Index (RSI)
- IKNA 36.12
- ICLK 51.69
- Support Level
- IKNA $1.45
- ICLK $7.78
- Resistance Level
- IKNA $1.53
- ICLK $9.16
- Average True Range (ATR)
- IKNA 0.06
- ICLK 0.84
- MACD
- IKNA -0.00
- ICLK -0.09
- Stochastic Oscillator
- IKNA 23.53
- ICLK 61.16
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About ICLK iClick Interactive Asia Group Limited
iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.